pharmaceutical-patents
2 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 23A344 | Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc., et al. | Federal Circuit | 2023-10-17 | Presumed Complete | KSR-standard obviousness patent-law pharmaceutical-patents predictable-result prior-art | This is an application for an extension of time to file a petition for a writ of certiorari, not a petition itself. The document does not contain a "Q… | |
| 18-182 | AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc., et al. | Federal Circuit | 2018-08-09 | Denied | Response Waived | actual-controversy article-iii declaratory-judgment drug-exclusivity fda-approval generic-drugs patent-invalidity pharmaceutical pharmaceutical-patents standing | In the context of patent cases involving pharmaceutical products, does the "actual controversy" requirement of the Declaratory Judgment Act, 28 U.S.C.… |